Toxicology

A founder says the company has a regulatory roadmap. The slide looks polished. The milestones look neat. The dates seem aggressive, but still believable. An investor flips through it and thinks one thing: Can I trust this? That is the real test.

The timeline looked brilliant. Prototype by June.Verification by September.FDA meeting by November.Submission next year. Clean. Sharp. Reassuring. Then reality showed up. One design change delayed testing.A […]

Everything looks fine until FDA responds. The roadmap is on track. The milestones are moving. The team is hitting deadlines. Then the feedback arrives. FDA wants […]

A medical device company can look perfectly organized on paper and still be heading toward a regulatory mess. The timeline may look polished.Prototype by Q2. Verification […]